Drug information for RETROVIR

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 100MG Prescription AB (Reference Drug) ZIDOVUDINE Zidovudine VIIV HLTHCARE 19655
2011-12-01 Letter
2011-11-25 Label
2010-05-21 Letter
2010-05-18 Label
2010-01-06 Letter
2009-11-23 Label
2008-09-25 Label
2008-09-23 Letter
2006-11-22 Letter
2006-11-16 Label
2006-05-18 Letter
2006-05-16 Label
2005-04-19 Review
2003-10-17 Letter
2003-10-17 Label
2003-06-16 Label
2003-04-04 Label
2002-12-18 Letter
2002-02-21 Letter
2001-03-30 Letter
2001-03-30 Label
INJECTABLE; INJECTION 10MG/ML Prescription AP (Reference Drug) ZIDOVUDINE Zidovudine VIIV HLTHCARE 19951
2011-11-28 Letter
2011-11-25 Label
2006-11-22 Letter
2006-07-13 Label
2006-07-13 Letter
2004-06-16 Letter
2003-08-15 Letter
2003-08-14 Label
2003-08-06 Label
2003-06-10 Label
2002-02-21 Letter
SYRUP; ORAL 50MG/5ML Prescription AA (Reference Drug) ZIDOVUDINE Zidovudine VIIV HLTHCARE 19910
2011-12-01 Letter
2011-11-25 Label
2010-05-21 Letter
2010-05-18 Label
2010-01-07 Letter
2009-11-19 Label
2008-09-23 Letter
2008-09-23 Label
2006-11-22 Letter
2006-11-16 Label
2006-05-18 Letter
2006-05-16 Label
2005-04-19 Review
2003-10-17 Letter
2003-10-17 Label
2003-06-10 Label
2003-04-04 Label
2002-12-18 Letter
2002-02-21 Letter
2001-03-30 Letter
2001-03-30 Label
TABLET; ORAL 200MG Discontinued   ZIDOVUDINE Zidovudine VIIV HLTHCARE 20518
2011-12-01 Letter
2011-11-25 Label
2010-05-21 Letter
2010-05-18 Label
2010-01-06 Letter
2009-11-23 Label
2008-09-25 Label
2008-09-23 Letter
2006-12-04 Letter
2006-11-22 Label
2006-05-18 Letter
2006-05-16 Label
2005-04-19 Review
2004-03-11 Label
2004-03-11 Letter
2003-04-25 Label
2003-04-04 Label
2002-12-18 Letter
2002-02-21 Letter
2001-03-30 Label
2001-03-30 Letter
TABLET; ORAL 300MG Prescription AB (Reference Drug) ZIDOVUDINE Zidovudine VIIV HLTHCARE   "

Drug Adverse Effects information for RETROVIR

Role code Indications Reaction # Reports
PS ANTIRETROVIRAL THERAPY FOETAL EXPOSURE DURING PREGNANCY 1
PS ANTIVIRAL TREATMENT FOETAL EXPOSURE DURING PREGNANCY 2
PS ANTIVIRAL TREATMENT MATERNAL EXPOSURE DURING PREGNANCY 3
PS ANTIVIRAL TREATMENT PREMATURE RUPTURE OF MEMBRANES 3
PS ANTIVIRAL TREATMENT STILLBIRTH 3
PS HIV INFECTION ANAEMIA 2
PS HIV INFECTION ARTERIOSCLEROSIS 1
PS HIV INFECTION BASEDOW'S DISEASE 3
PS HIV INFECTION DIABETES MELLITUS 1
PS HIV INFECTION FOETAL EXPOSURE DURING PREGNANCY 2
PS HIV INFECTION HEPATIC NEOPLASM MALIGNANT 1
PS HIV INFECTION OVERDOSE 1
PS HIV INFECTION PANCREATITIS 1
PS PROPHYLAXIS AGAINST HIV INFECTION ANAEMIA 5
PS PROPHYLAXIS AGAINST HIV INFECTION AUTISM 3
PS PROPHYLAXIS AGAINST HIV INFECTION CAESAREAN SECTION 3
PS PROPHYLAXIS AGAINST HIV INFECTION FOETAL DISTRESS SYNDROME 3
PS PROPHYLAXIS AGAINST HIV INFECTION FOETAL EXPOSURE DURING PREGNANCY 2
PS PROPHYLAXIS AGAINST HIV INFECTION MATERNAL DRUGS AFFECTING FOETUS 3
PS PROPHYLAXIS AGAINST HIV INFECTION MATERNAL EXPOSURE DURING PREGNANCY 3
PS PROPHYLAXIS AGAINST HIV INFECTION PREMATURE BABY 3
PS PROPHYLAXIS AGAINST HIV INFECTION SPEECH DISORDER DEVELOPMENTAL 3
SS ANTIRETROVIRAL THERAPY ALANINE AMINOTRANSFERASE INCREASED 3
SS ANTIRETROVIRAL THERAPY ANAEMIA 3
SS ANTIRETROVIRAL THERAPY APHASIA 3
SS ANTIRETROVIRAL THERAPY APRAXIA 3
SS ANTIRETROVIRAL THERAPY ASPARTATE AMINOTRANSFERASE INCREASED 3
SS ANTIRETROVIRAL THERAPY BIPOLAR I DISORDER 6
SS ANTIRETROVIRAL THERAPY CEREBRAL TOXOPLASMOSIS 3
SS ANTIRETROVIRAL THERAPY CONFUSIONAL STATE 3
SS ANTIRETROVIRAL THERAPY DEPRESSION 6
SS ANTIRETROVIRAL THERAPY ERYTHROPENIA 3
SS ANTIRETROVIRAL THERAPY FOETAL EXPOSURE DURING PREGNANCY 7
SS ANTIRETROVIRAL THERAPY GAMMA-GLUTAMYLTRANSFERASE INCREASED 3
SS ANTIRETROVIRAL THERAPY LEUKOPENIA 3
SS ANTIRETROVIRAL THERAPY LYMPHOPENIA 3
SS ANTIRETROVIRAL THERAPY NO ADVERSE EVENT 6
SS ANTIRETROVIRAL THERAPY SEXUALLY TRANSMITTED DISEASE 6
SS ANTIRETROVIRAL THERAPY STATUS EPILEPTICUS 3
SS ANTIRETROVIRAL THERAPY THROMBOCYTOPENIA 6
SS ANTIRETROVIRAL THERAPY TREATMENT NONCOMPLIANCE 6
SS ANTIRETROVIRAL THERAPY VAGINITIS BACTERIAL 8
SS ANTIRETROVIRAL THERAPY VOMITING 3
SS ANTIVIRAL TREATMENT FOETAL EXPOSURE DURING PREGNANCY 6
SS ANTIVIRAL TREATMENT MATERNAL EXPOSURE DURING PREGNANCY 9
SS ANTIVIRAL TREATMENT NO ADVERSE EVENT 4
SS ANTIVIRAL TREATMENT PREMATURE DELIVERY 6
SS ANTIVIRAL TREATMENT PREMATURE RUPTURE OF MEMBRANES 3
SS ANTIVIRAL TREATMENT STILLBIRTH 3
SS DIARRHOEA BLOOD GLUCOSE INCREASED 2
SS DIARRHOEA GLUCOSE URINE PRESENT 2
SS DIARRHOEA HEPATIC FUNCTION ABNORMAL 2
SS DIARRHOEA HYPERLIPIDAEMIA 2
SS DIARRHOEA METASTASES TO BONE 2
SS DIARRHOEA SPINAL COMPRESSION FRACTURE 2
SS HIV INFECTION ABDOMINAL DISTENSION 16
SS HIV INFECTION ABDOMINAL HERNIA 7
SS HIV INFECTION ANAEMIA 12
SS HIV INFECTION ANAEMIA NEONATAL 5
SS HIV INFECTION ANAEMIA OF PREGNANCY 5
SS HIV INFECTION BLOOD GLUCOSE INCREASED 2
SS HIV INFECTION BLOOD TRIGLYCERIDES INCREASED 14
SS HIV INFECTION CAESAREAN SECTION 3
SS HIV INFECTION CARDIAC MURMUR 7
SS HIV INFECTION CONDITION AGGRAVATED 3
SS HIV INFECTION CONGENITAL ANOMALY 7
SS HIV INFECTION CRYPTORCHISM 7
SS HIV INFECTION EXOMPHALOS 7
SS HIV INFECTION FOETAL EXPOSURE DURING PREGNANCY 5
SS HIV INFECTION GASTROSCHISIS 7
SS HIV INFECTION GLUCOSE URINE PRESENT 2
SS HIV INFECTION HEPATIC FUNCTION ABNORMAL 2
SS HIV INFECTION HYPERLIPIDAEMIA 2
SS HIV INFECTION LIVE BIRTH 10
SS HIV INFECTION MATERNAL DRUGS AFFECTING FOETUS 7
SS HIV INFECTION MATERNAL EXPOSURE DURING PREGNANCY 5
SS HIV INFECTION MATERNAL EXPOSURE TIMING UNSPECIFIED 3
SS HIV INFECTION METASTASES TO BONE 2
SS HIV INFECTION NEONATAL TACHYPNOEA 5
SS HIV INFECTION OPERATIVE HAEMORRHAGE 3
SS HIV INFECTION PORTAL HYPERTENSION 8
SS HIV INFECTION PREGNANCY 16
SS HIV INFECTION PREMATURE DELIVERY 5
SS HIV INFECTION PREMATURE LABOUR 9
SS HIV INFECTION SPINAL COMPRESSION FRACTURE 2
SS HIV INFECTION STILLBIRTH 3
SS HIV INFECTION THREATENED LABOUR 5
SS HIV INFECTION UMBILICAL HERNIA 7
SS HIV INFECTION UTERINE HAEMORRHAGE 3
SS MATERNAL EXPOSURE DURING PREGNANCY FOETAL ARRHYTHMIA 3
SS MATERNAL EXPOSURE DURING PREGNANCY MATERNAL EXPOSURE DURING PREGNANCY 11
SS MATERNAL EXPOSURE DURING PREGNANCY NEURAL TUBE DEFECT 8
SS MATERNAL EXPOSURE TIMING UNSPECIFIED ANAEMIA 5
SS MATERNAL EXPOSURE TIMING UNSPECIFIED COUGH 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED DROOLING 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED DYSPHONIA 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED FOETAL EXPOSURE DURING PREGNANCY 22
SS MATERNAL EXPOSURE TIMING UNSPECIFIED FOETAL HEART RATE DISORDER 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED FUNGAL INFECTION 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED OESOPHAGEAL ATRESIA 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED ORAL CANDIDIASIS 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED OXYGEN SATURATION DECREASED 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED PREMATURE BABY 4
SS MATERNAL EXPOSURE TIMING UNSPECIFIED REGURGITATION 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED TACHYPNOEA 5
SS MATERNAL EXPOSURE TIMING UNSPECIFIED TRACHEOMALACIA 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED UNDERWEIGHT 4
SS MATERNAL EXPOSURE TIMING UNSPECIFIED VENOUS THROMBOSIS LIMB 9
SS PREGNANCY DIABETES MELLITUS 1
SS PRODUCT USED FOR UNKNOWN INDICATION ABDOMINAL DISTENSION 3
SS PRODUCT USED FOR UNKNOWN INDICATION ABDOMINAL HERNIA 1
SS PRODUCT USED FOR UNKNOWN INDICATION ALANINE AMINOTRANSFERASE INCREASED 12
SS PRODUCT USED FOR UNKNOWN INDICATION ANAEMIA 14
SS PRODUCT USED FOR UNKNOWN INDICATION APHASIA 12
SS PRODUCT USED FOR UNKNOWN INDICATION APRAXIA 12
SS PRODUCT USED FOR UNKNOWN INDICATION ASPARTATE AMINOTRANSFERASE INCREASED 12
SS PRODUCT USED FOR UNKNOWN INDICATION BIPOLAR I DISORDER 4
SS PRODUCT USED FOR UNKNOWN INDICATION BLOOD TRIGLYCERIDES INCREASED 2
SS PRODUCT USED FOR UNKNOWN INDICATION CARDIAC MURMUR 1
SS PRODUCT USED FOR UNKNOWN INDICATION CEREBRAL TOXOPLASMOSIS 12
SS PRODUCT USED FOR UNKNOWN INDICATION CONFUSIONAL STATE 12
SS PRODUCT USED FOR UNKNOWN INDICATION CONGENITAL ANOMALY 1
SS PRODUCT USED FOR UNKNOWN INDICATION CRYPTORCHISM 1
SS PRODUCT USED FOR UNKNOWN INDICATION DEPRESSION 4
SS PRODUCT USED FOR UNKNOWN INDICATION DIABETES MELLITUS 6
SS PRODUCT USED FOR UNKNOWN INDICATION ERYTHROPENIA 12
SS PRODUCT USED FOR UNKNOWN INDICATION EXOMPHALOS 1
SS PRODUCT USED FOR UNKNOWN INDICATION GAMMA-GLUTAMYLTRANSFERASE INCREASED 12
SS PRODUCT USED FOR UNKNOWN INDICATION GASTROSCHISIS 1
SS PRODUCT USED FOR UNKNOWN INDICATION LEUKOPENIA 12
SS PRODUCT USED FOR UNKNOWN INDICATION LYMPHOPENIA 12
SS PRODUCT USED FOR UNKNOWN INDICATION MATERNAL DRUGS AFFECTING FOETUS 1
SS PRODUCT USED FOR UNKNOWN INDICATION PREMATURE LABOUR 2
SS PRODUCT USED FOR UNKNOWN INDICATION SEXUALLY TRANSMITTED DISEASE 6
SS PRODUCT USED FOR UNKNOWN INDICATION STATUS EPILEPTICUS 12
SS PRODUCT USED FOR UNKNOWN INDICATION THROMBOCYTOPENIA 4
SS PRODUCT USED FOR UNKNOWN INDICATION TREATMENT NONCOMPLIANCE 4
SS PRODUCT USED FOR UNKNOWN INDICATION UMBILICAL HERNIA 1
SS PRODUCT USED FOR UNKNOWN INDICATION VAGINITIS BACTERIAL 2
SS PRODUCT USED FOR UNKNOWN INDICATION VOMITING 12
SS PROPHYLAXIS AGAINST HIV INFECTION ANAEMIA 3
SS PROPHYLAXIS AGAINST HIV INFECTION AUTISM 3
SS PROPHYLAXIS AGAINST HIV INFECTION CAESAREAN SECTION 3
SS PROPHYLAXIS AGAINST HIV INFECTION FOETAL DISTRESS SYNDROME 3
SS PROPHYLAXIS AGAINST HIV INFECTION MATERNAL DRUGS AFFECTING FOETUS 3
SS PROPHYLAXIS AGAINST HIV INFECTION MATERNAL EXPOSURE DURING PREGNANCY 3
SS PROPHYLAXIS AGAINST HIV INFECTION PREMATURE BABY 3
SS PROPHYLAXIS AGAINST HIV INFECTION SPEECH DISORDER DEVELOPMENTAL 3
SS VITAMIN SUPPLEMENTATION VAGINITIS BACTERIAL 2
C DIABETES MELLITUS ABDOMINAL DISTENSION 2
C DIABETES MELLITUS ACQUIRED IMMUNODEFICIENCY SYNDROME 2
C DIABETES MELLITUS ASCITES 2
C DIABETES MELLITUS ATRIOVENTRICULAR BLOCK SECOND DEGREE 2
C DIABETES MELLITUS ATRIOVENTRICULAR DISSOCIATION 2
C DIABETES MELLITUS BRADYCARDIA 2
C DIABETES MELLITUS HEPATIC CIRRHOSIS 2
C DIABETES MELLITUS HYPOALBUMINAEMIA 2
C DIABETES MELLITUS HYPONATRAEMIA 2
C DIABETES MELLITUS HYPOTHYROIDISM 2
C DIABETES MELLITUS INGUINAL HERNIA 2
C DIABETES MELLITUS INTERNATIONAL NORMALISED RATIO INCREASED 2
C DIABETES MELLITUS LUNG INFILTRATION 2
C DIABETES MELLITUS PAIN 2
C DIABETES MELLITUS PANCYTOPENIA 2
C DIABETES MELLITUS PLASMABLASTIC LYMPHOMA 2
C DIABETES MELLITUS RIGHT VENTRICULAR FAILURE 2
C DIABETES MELLITUS VENTRICULAR TACHYCARDIA 2
C GOUT INFUSION RELATED REACTION 1
C GOUT MUSCLE SPASMS 1
C GOUT NASAL DISCOMFORT 1
C HIV INFECTION ABDOMINAL DISTENSION 4
C HIV INFECTION ACQUIRED IMMUNODEFICIENCY SYNDROME 4
C HIV INFECTION AGEUSIA 1
C HIV INFECTION ARTHRALGIA 1
C HIV INFECTION ASCITES 4
C HIV INFECTION ATRIOVENTRICULAR BLOCK SECOND DEGREE 4
C HIV INFECTION ATRIOVENTRICULAR DISSOCIATION 4
C HIV INFECTION BRADYCARDIA 4
C HIV INFECTION DYSGEUSIA 1
C HIV INFECTION HEPATIC CIRRHOSIS 4
C HIV INFECTION HYPERSENSITIVITY 1
C HIV INFECTION HYPOAESTHESIA 1
C HIV INFECTION HYPOALBUMINAEMIA 4
C HIV INFECTION HYPONATRAEMIA 4
C HIV INFECTION HYPOSPADIAS 2
C HIV INFECTION HYPOTHYROIDISM 4
C HIV INFECTION INGUINAL HERNIA 4
C HIV INFECTION INTERNATIONAL NORMALISED RATIO INCREASED 4
C HIV INFECTION LUNG INFILTRATION 4
C HIV INFECTION MENINGOCELE 4
C HIV INFECTION MYALGIA 1
C HIV INFECTION NEURAL TUBE DEFECT 8
C HIV INFECTION OEDEMA PERIPHERAL 1
C HIV INFECTION PAIN 4
C HIV INFECTION PAIN IN EXTREMITY 1
C HIV INFECTION PANCYTOPENIA 4
C HIV INFECTION PENILE CURVATURE 2
C HIV INFECTION PHARYNGITIS 1
C HIV INFECTION PLASMABLASTIC LYMPHOMA 4
C HIV INFECTION RIGHT VENTRICULAR FAILURE 4
C HIV INFECTION VENTRICULAR TACHYCARDIA 4
C HYPERLIPIDAEMIA ABDOMINAL DISTENSION 1
C HYPERLIPIDAEMIA ACQUIRED IMMUNODEFICIENCY SYNDROME 1
C HYPERLIPIDAEMIA ASCITES 1
C HYPERLIPIDAEMIA ATRIOVENTRICULAR BLOCK SECOND DEGREE 1
C HYPERLIPIDAEMIA ATRIOVENTRICULAR DISSOCIATION 1
C HYPERLIPIDAEMIA BRADYCARDIA 1
C HYPERLIPIDAEMIA HEPATIC CIRRHOSIS 1
C HYPERLIPIDAEMIA HYPOALBUMINAEMIA 1
C HYPERLIPIDAEMIA HYPONATRAEMIA 1
C HYPERLIPIDAEMIA HYPOTHYROIDISM 1
C HYPERLIPIDAEMIA INGUINAL HERNIA 1
C HYPERLIPIDAEMIA INTERNATIONAL NORMALISED RATIO INCREASED 1
C HYPERLIPIDAEMIA LUNG INFILTRATION 1
C HYPERLIPIDAEMIA PAIN 1
C HYPERLIPIDAEMIA PANCYTOPENIA 1
C HYPERLIPIDAEMIA PLASMABLASTIC LYMPHOMA 1
C HYPERLIPIDAEMIA RIGHT VENTRICULAR FAILURE 1
C HYPERLIPIDAEMIA VENTRICULAR TACHYCARDIA 1
C HYPERTENSION ABDOMINAL DISTENSION 1
C HYPERTENSION ACQUIRED IMMUNODEFICIENCY SYNDROME 1
C HYPERTENSION ASCITES 1
C HYPERTENSION ATRIOVENTRICULAR BLOCK SECOND DEGREE 1
C HYPERTENSION ATRIOVENTRICULAR DISSOCIATION 1
C HYPERTENSION BRADYCARDIA 1
C HYPERTENSION HEPATIC CIRRHOSIS 1
C HYPERTENSION HYPOALBUMINAEMIA 1
C HYPERTENSION HYPONATRAEMIA 1
C HYPERTENSION HYPOTHYROIDISM 1
C HYPERTENSION INGUINAL HERNIA 1
C HYPERTENSION INTERNATIONAL NORMALISED RATIO INCREASED 1
C HYPERTENSION LUNG INFILTRATION 1
C HYPERTENSION PAIN 1
C HYPERTENSION PANCYTOPENIA 1
C HYPERTENSION PLASMABLASTIC LYMPHOMA 1
C HYPERTENSION RIGHT VENTRICULAR FAILURE 1
C HYPERTENSION VENTRICULAR TACHYCARDIA 1
C PRODUCT USED FOR UNKNOWN INDICATION ABDOMINAL DISTENSION 6
C PRODUCT USED FOR UNKNOWN INDICATION ACQUIRED IMMUNODEFICIENCY SYNDROME 6
C PRODUCT USED FOR UNKNOWN INDICATION ASCITES 6
C PRODUCT USED FOR UNKNOWN INDICATION ATRIOVENTRICULAR BLOCK SECOND DEGREE 6
C PRODUCT USED FOR UNKNOWN INDICATION ATRIOVENTRICULAR DISSOCIATION 6
C PRODUCT USED FOR UNKNOWN INDICATION BRADYCARDIA 6
C PRODUCT USED FOR UNKNOWN INDICATION HEPATIC CIRRHOSIS 6
C PRODUCT USED FOR UNKNOWN INDICATION HYPOALBUMINAEMIA 6
C PRODUCT USED FOR UNKNOWN INDICATION HYPONATRAEMIA 6
C PRODUCT USED FOR UNKNOWN INDICATION HYPOTHYROIDISM 6
C PRODUCT USED FOR UNKNOWN INDICATION INGUINAL HERNIA 6
C PRODUCT USED FOR UNKNOWN INDICATION INTERNATIONAL NORMALISED RATIO INCREASED 6
C PRODUCT USED FOR UNKNOWN INDICATION LUNG INFILTRATION 6
C PRODUCT USED FOR UNKNOWN INDICATION PAIN 6
C PRODUCT USED FOR UNKNOWN INDICATION PANCYTOPENIA 6
C PRODUCT USED FOR UNKNOWN INDICATION PLASMABLASTIC LYMPHOMA 6
C PRODUCT USED FOR UNKNOWN INDICATION RIGHT VENTRICULAR FAILURE 6
C PRODUCT USED FOR UNKNOWN INDICATION VENTRICULAR TACHYCARDIA 6
C PROPHYLAXIS AGAINST HIV INFECTION BLOOD GLUCOSE INCREASED 2
C PROPHYLAXIS AGAINST HIV INFECTION BLOOD PH DECREASED 1
C PROPHYLAXIS AGAINST HIV INFECTION MEDICATION ERROR 2
C PROPHYLAXIS AGAINST HIV INFECTION MUSCLE TWITCHING 2
C PROPHYLAXIS AGAINST HIV INFECTION PCO2 INCREASED 1
C PROPHYLAXIS AGAINST HIV INFECTION PYREXIA 3
C PROPHYLAXIS AGAINST HIV INFECTION SOMNOLENCE 3
C PROPHYLAXIS AGAINST HIV INFECTION TACHYPNOEA 3
Ads by Google